1. As a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma
   Ryosuke Desaki et al, 2017, Annals of Surgical Oncology CrossRef
2. MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma
   Qiyu Luo et al, 2021, Frontiers in Oncology CrossRef